Amdocs (NASDAQ:DOX) Rating Lowered to Hold at Wall Street Zen

Amdocs (NASDAQ:DOXGet Free Report) was downgraded by equities research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Saturday.

DOX has been the topic of several other reports. Barclays dropped their price objective on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a report on Wednesday, February 4th. Weiss Ratings restated a “hold (c)” rating on shares of Amdocs in a research report on Tuesday, January 27th. Finally, Stifel Nicolaus cut their price target on Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday, February 4th. Three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $92.33.

Read Our Latest Analysis on Amdocs

Amdocs Price Performance

Shares of DOX stock opened at $64.83 on Friday. Amdocs has a 52-week low of $63.53 and a 52-week high of $95.41. The firm has a market capitalization of $7.00 billion, a P/E ratio of 12.54, a P/E/G ratio of 1.14 and a beta of 0.42. The stock has a 50 day moving average price of $73.35 and a 200 day moving average price of $78.52. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.06.

Amdocs (NASDAQ:DOXGet Free Report) last issued its earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.75 by $0.06. The business had revenue of $1.16 billion during the quarter, compared to analysts’ expectations of $1.15 billion. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.The business’s revenue for the quarter was up 4.1% compared to the same quarter last year. During the same period in the prior year, the business earned $1.66 EPS. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. As a group, sell-side analysts predict that Amdocs will post 6.21 earnings per share for the current year.

Hedge Funds Weigh In On Amdocs

Institutional investors and hedge funds have recently bought and sold shares of the company. Harbor Capital Advisors Inc. acquired a new stake in Amdocs during the third quarter worth $26,000. Root Financial Partners LLC purchased a new position in shares of Amdocs in the third quarter valued at approximately $26,000. WealthCollab LLC grew its stake in shares of Amdocs by 94.5% in the third quarter. WealthCollab LLC now owns 356 shares of the technology company’s stock worth $29,000 after acquiring an additional 173 shares in the last quarter. Atlantic Union Bankshares Corp acquired a new position in Amdocs during the 3rd quarter worth $37,000. Finally, BOK Financial Private Wealth Inc. purchased a new stake in shares of Amdocs during the fourth quarter worth approximately $37,000. 92.02% of the stock is currently owned by institutional investors and hedge funds.

About Amdocs

(Get Free Report)

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.

See Also

Analyst Recommendations for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.